Probiotic therapy in radiation-induced intestinal injury and repair
- PMID: 19538306
- PMCID: PMC4063203
- DOI: 10.1111/j.1749-6632.2009.04029.x
Probiotic therapy in radiation-induced intestinal injury and repair
Abstract
Intestinal injury from ionizing radiation is a clinically important entity, as enteritis symptoms occur commonly after radiotherapy for pelvic malignancies. Preventative or therapeutic options for radiation enteritis are mostly unsatisfactory; however, available data suggests that probiotic bacteria--those which confer health benefit--may have therapeutic value. Previous reports from both human trials and animal models have evaluated various end points for probiotic usage in limiting radiation-associated intestinal damage. Newer data suggests that particular probiotics and/or their secreted or derived bacterial products may have unique radioprotective properties. We will review the area with a focus on new developments surrounding probiotic therapy in radiation-induced intestinal injury and repair.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Zimmerer T, et al. Medical prevention and treatment of acute and chronic radiation induced enteritis – is there any proven therapy? A short review. Z Gastroenterol. 2008;46:441–448. - PubMed
-
- Stenson WF. Toll-like receptors and intestinal epithelial repair. Curr Opin Gastroenterol. 2008;24:103–107. - PubMed
-
- Riehl T, et al. Radiation-induced Apoptosis is increased in MyD88-/- mice and the increase is reversed by PGE2 [abstract] Gastroenterology. 2007;132:A-566.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
